nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethanolamine Oleate—FABP5—prostate gland—urinary bladder cancer	0.0511	0.142	CbGeAlD
Ethanolamine Oleate—FABP4—prostate gland—urinary bladder cancer	0.0478	0.133	CbGeAlD
Ethanolamine Oleate—FABP5—epithelium—urinary bladder cancer	0.0376	0.105	CbGeAlD
Ethanolamine Oleate—FABP4—renal system—urinary bladder cancer	0.0326	0.0908	CbGeAlD
Ethanolamine Oleate—F12—vagina—urinary bladder cancer	0.0297	0.0827	CbGeAlD
Ethanolamine Oleate—FABP5—female reproductive system—urinary bladder cancer	0.0279	0.0777	CbGeAlD
Ethanolamine Oleate—FABP4—female reproductive system—urinary bladder cancer	0.0261	0.0727	CbGeAlD
Ethanolamine Oleate—FABP4—vagina—urinary bladder cancer	0.0236	0.0657	CbGeAlD
Ethanolamine Oleate—CYP2E1—urine—urinary bladder cancer	0.0218	0.0607	CbGeAlD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—MT2A—urinary bladder cancer	0.0209	0.0792	CbGpPWpGaD
Ethanolamine Oleate—F12—Blood Clotting Cascade—PLAU—urinary bladder cancer	0.02	0.076	CbGpPWpGaD
Ethanolamine Oleate—Alpha-Linolenic Acid—TRPV1—urinary bladder cancer	0.0192	0.845	CrCbGaD
Ethanolamine Oleate—Necrosis—Mitomycin—urinary bladder cancer	0.0176	0.054	CcSEcCtD
Ethanolamine Oleate—FABP5—lymph node—urinary bladder cancer	0.0163	0.0455	CbGeAlD
Ethanolamine Oleate—FABP4—lymph node—urinary bladder cancer	0.0153	0.0425	CbGeAlD
Ethanolamine Oleate—Ulcer—Mitomycin—urinary bladder cancer	0.0146	0.0448	CcSEcCtD
Ethanolamine Oleate—FABP5—Idarubicin—Valrubicin—urinary bladder cancer	0.0124	0.428	CbGdCrCtD
Ethanolamine Oleate—Pneumonia—Valrubicin—urinary bladder cancer	0.0113	0.0346	CcSEcCtD
Ethanolamine Oleate—Lacrimation—Fluorouracil—urinary bladder cancer	0.00975	0.03	CcSEcCtD
Ethanolamine Oleate—F12—Complement and Coagulation Cascades—PLAU—urinary bladder cancer	0.0091	0.0345	CbGpPWpGaD
Ethanolamine Oleate—FABP5—Teniposide—Etoposide—urinary bladder cancer	0.00827	0.285	CbGdCrCtD
Ethanolamine Oleate—CYP2E1—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.0081	0.0307	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—prostate gland—urinary bladder cancer	0.00783	0.0218	CbGeAlD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—NCOR1—urinary bladder cancer	0.0077	0.0292	CbGpPWpGaD
Ethanolamine Oleate—Oesophageal ulcer—Epirubicin—urinary bladder cancer	0.00765	0.0235	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Gemcitabine—urinary bladder cancer	0.00761	0.0234	CcSEcCtD
Ethanolamine Oleate—Chest pain—Valrubicin—urinary bladder cancer	0.00744	0.0229	CcSEcCtD
Ethanolamine Oleate—Necrosis—Fluorouracil—urinary bladder cancer	0.0073	0.0224	CcSEcCtD
Ethanolamine Oleate—Oesophageal ulcer—Doxorubicin—urinary bladder cancer	0.00708	0.0217	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.00694	0.0263	CbGpPWpGaD
Ethanolamine Oleate—Retrosternal pain—Epirubicin—urinary bladder cancer	0.00693	0.0213	CcSEcCtD
Ethanolamine Oleate—Necrosis—Cisplatin—urinary bladder cancer	0.00692	0.0213	CcSEcCtD
Ethanolamine Oleate—Abscess—Cisplatin—urinary bladder cancer	0.00687	0.0211	CcSEcCtD
Ethanolamine Oleate—CYP2E1—seminal vesicle—urinary bladder cancer	0.00662	0.0184	CbGeAlD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00657	0.0249	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.00653	0.0248	CbGpPWpGaD
Ethanolamine Oleate—Retrosternal pain—Doxorubicin—urinary bladder cancer	0.00641	0.0197	CcSEcCtD
Ethanolamine Oleate—Necrosis—Etoposide—urinary bladder cancer	0.00634	0.0195	CcSEcCtD
Ethanolamine Oleate—Oesophagitis—Thiotepa—urinary bladder cancer	0.00633	0.0195	CcSEcCtD
Ethanolamine Oleate—Lacrimation increased—Fluorouracil—urinary bladder cancer	0.00622	0.0191	CcSEcCtD
Ethanolamine Oleate—Ulcer—Gemcitabine—urinary bladder cancer	0.00616	0.0189	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—CDK4—urinary bladder cancer	0.00608	0.023	CbGpPWpGaD
Ethanolamine Oleate—Ulcer—Fluorouracil—urinary bladder cancer	0.00606	0.0186	CcSEcCtD
Ethanolamine Oleate—Ulcer—Cisplatin—urinary bladder cancer	0.00575	0.0177	CcSEcCtD
Ethanolamine Oleate—Pain—Carboplatin—urinary bladder cancer	0.00565	0.0174	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Valrubicin—urinary bladder cancer	0.00564	0.0173	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—PPARG—urinary bladder cancer	0.00552	0.0209	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—renal system—urinary bladder cancer	0.00534	0.0149	CbGeAlD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—CREBBP—urinary bladder cancer	0.0053	0.0201	CbGpPWpGaD
Ethanolamine Oleate—Ulcer—Etoposide—urinary bladder cancer	0.00526	0.0162	CcSEcCtD
Ethanolamine Oleate—CYP2E1—urethra—urinary bladder cancer	0.00524	0.0146	CbGeAlD
Ethanolamine Oleate—Oesophagitis—Fluorouracil—urinary bladder cancer	0.00524	0.0161	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Carboplatin—urinary bladder cancer	0.00522	0.0161	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00501	0.019	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00496	0.0188	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation—Epirubicin—urinary bladder cancer	0.00475	0.0146	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00473	0.0179	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CNTN2—urinary bladder cancer	0.00465	0.0176	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Etoposide—urinary bladder cancer	0.00455	0.014	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.00454	0.0172	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation—Doxorubicin—urinary bladder cancer	0.00439	0.0135	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—IL2—urinary bladder cancer	0.00434	0.0165	CbGpPWpGaD
Ethanolamine Oleate—FABP5—Idarubicin—Epirubicin—urinary bladder cancer	0.00431	0.149	CbGdCrCtD
Ethanolamine Oleate—CYP2E1—female reproductive system—urinary bladder cancer	0.00427	0.0119	CbGeAlD
Ethanolamine Oleate—Renal failure acute—Cisplatin—urinary bladder cancer	0.00427	0.0131	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.00423	0.0161	CbGpPWpGaD
Ethanolamine Oleate—Pain—Mitomycin—urinary bladder cancer	0.0042	0.0129	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—urinary bladder cancer	0.00417	0.0158	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.00411	0.0156	CbGpPWpGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.00409	0.0155	CbGpPWpGaD
Ethanolamine Oleate—FABP5—Idarubicin—Doxorubicin—urinary bladder cancer	0.00399	0.138	CbGdCrCtD
Ethanolamine Oleate—Pneumonia—Thiotepa—urinary bladder cancer	0.0039	0.012	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—EP300—urinary bladder cancer	0.0039	0.0148	CbGpPWpGaD
Ethanolamine Oleate—Pleural effusion—Methotrexate—urinary bladder cancer	0.00389	0.012	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Mitomycin—urinary bladder cancer	0.00389	0.0119	CcSEcCtD
Ethanolamine Oleate—Necrosis—Methotrexate—urinary bladder cancer	0.0038	0.0117	CcSEcCtD
Ethanolamine Oleate—Abscess—Methotrexate—urinary bladder cancer	0.00377	0.0116	CcSEcCtD
Ethanolamine Oleate—Pleural effusion—Epirubicin—urinary bladder cancer	0.00364	0.0112	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—EP300—urinary bladder cancer	0.00361	0.0137	CbGpPWpGaD
Ethanolamine Oleate—Necrosis—Epirubicin—urinary bladder cancer	0.00356	0.0109	CcSEcCtD
Ethanolamine Oleate—Abscess—Epirubicin—urinary bladder cancer	0.00353	0.0108	CcSEcCtD
Ethanolamine Oleate—Dihomo-gamma-linolenic acid—PTGS2—urinary bladder cancer	0.00351	0.155	CrCbGaD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—MYC—urinary bladder cancer	0.0034	0.0129	CbGpPWpGaD
Ethanolamine Oleate—Pleural effusion—Doxorubicin—urinary bladder cancer	0.00337	0.0104	CcSEcCtD
Ethanolamine Oleate—Necrosis—Doxorubicin—urinary bladder cancer	0.00329	0.0101	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Gemcitabine—urinary bladder cancer	0.00328	0.0101	CcSEcCtD
Ethanolamine Oleate—Abscess—Doxorubicin—urinary bladder cancer	0.00326	0.01	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Fluorouracil—urinary bladder cancer	0.00323	0.00991	CcSEcCtD
Ethanolamine Oleate—Ulcer—Methotrexate—urinary bladder cancer	0.00315	0.00969	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00315	0.0119	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00311	0.0118	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00303	0.00931	CcSEcCtD
Ethanolamine Oleate—Ulcer—Epirubicin—urinary bladder cancer	0.00295	0.00907	CcSEcCtD
Ethanolamine Oleate—FABP4—Transcriptional regulation of white adipocyte differentiation—TNF—urinary bladder cancer	0.00293	0.0111	CbGpPWpGaD
Ethanolamine Oleate—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.0028	0.00861	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Etoposide—urinary bladder cancer	0.0028	0.00861	CcSEcCtD
Ethanolamine Oleate—FABP4—AP-1 transcription factor network—TP53—urinary bladder cancer	0.00279	0.0106	CbGpPWpGaD
Ethanolamine Oleate—Ulcer—Doxorubicin—urinary bladder cancer	0.00273	0.00839	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—GSTZ1—urinary bladder cancer	0.0027	0.0102	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTO2—urinary bladder cancer	0.00256	0.00971	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NAT1—urinary bladder cancer	0.00256	0.00971	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00255	0.00969	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Epirubicin—urinary bladder cancer	0.00255	0.00784	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.00252	0.00955	CbGpPWpGaD
Ethanolamine Oleate—Oesophagitis—Doxorubicin—urinary bladder cancer	0.00236	0.00725	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Methotrexate—urinary bladder cancer	0.00234	0.0072	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—UGT2B7—urinary bladder cancer	0.00234	0.00888	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—IFNA2—urinary bladder cancer	0.0023	0.00872	CbGpPWpGaD
Ethanolamine Oleate—Renal failure acute—Epirubicin—urinary bladder cancer	0.00219	0.00674	CcSEcCtD
Ethanolamine Oleate—Chest pain—Gemcitabine—urinary bladder cancer	0.00217	0.00667	CcSEcCtD
Ethanolamine Oleate—Chest pain—Fluorouracil—urinary bladder cancer	0.00213	0.00656	CcSEcCtD
Ethanolamine Oleate—Pain—Thiotepa—urinary bladder cancer	0.00211	0.0065	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—CYP4B1—urinary bladder cancer	0.00211	0.00799	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00208	0.00639	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00205	0.00628	CcSEcCtD
Ethanolamine Oleate—Renal failure acute—Doxorubicin—urinary bladder cancer	0.00203	0.00624	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—SLC19A1—urinary bladder cancer	0.00199	0.00755	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Thiotepa—urinary bladder cancer	0.00195	0.00601	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—PRSS3—urinary bladder cancer	0.00194	0.00736	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.00194	0.00596	CcSEcCtD
Ethanolamine Oleate—Chest pain—Etoposide—urinary bladder cancer	0.00185	0.00569	CcSEcCtD
Ethanolamine Oleate—Pain—Gemcitabine—urinary bladder cancer	0.00178	0.00547	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00178	0.00546	CcSEcCtD
Ethanolamine Oleate—Pain—Fluorouracil—urinary bladder cancer	0.00175	0.00537	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—NCOR1—urinary bladder cancer	0.00174	0.0066	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00174	0.00659	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00171	0.0065	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Methotrexate—urinary bladder cancer	0.00168	0.00516	CcSEcCtD
Ethanolamine Oleate—Pain—Cisplatin—urinary bladder cancer	0.00166	0.00509	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTO2—urinary bladder cancer	0.00165	0.00625	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—NAT1—urinary bladder cancer	0.00165	0.00625	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00164	0.00505	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—PLAU—urinary bladder cancer	0.00163	0.00619	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00163	0.00616	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00162	0.00497	CcSEcCtD
Ethanolamine Oleate—Pneumonia—Epirubicin—urinary bladder cancer	0.00157	0.00482	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.00155	0.0059	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TYMP—urinary bladder cancer	0.00155	0.00588	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Cisplatin—urinary bladder cancer	0.00153	0.00471	CcSEcCtD
Ethanolamine Oleate—Pain—Etoposide—urinary bladder cancer	0.00152	0.00467	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00151	0.00572	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.00149	0.00565	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00149	0.00564	CbGpPWpGaD
Ethanolamine Oleate—Pneumonia—Doxorubicin—urinary bladder cancer	0.00145	0.00446	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Etoposide—urinary bladder cancer	0.0014	0.00431	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—NAT2—urinary bladder cancer	0.0014	0.00532	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CDK4—urinary bladder cancer	0.00137	0.00521	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—CYP4B1—urinary bladder cancer	0.00136	0.00515	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—CREBBP—urinary bladder cancer	0.00135	0.0051	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00134	0.00508	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—IGF1—urinary bladder cancer	0.00133	0.00504	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—PPARG—urinary bladder cancer	0.00125	0.00473	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—RHOA—urinary bladder cancer	0.00122	0.00462	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—RRM2—urinary bladder cancer	0.00121	0.00459	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—CREBBP—urinary bladder cancer	0.0012	0.00455	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00117	0.00443	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—HPGDS—urinary bladder cancer	0.00112	0.00425	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ENO2—urinary bladder cancer	0.00112	0.00425	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00111	0.00423	CbGpPWpGaD
Ethanolamine Oleate—Chest pain—Methotrexate—urinary bladder cancer	0.00111	0.00341	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—GSTT1—urinary bladder cancer	0.00109	0.00412	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—RHOA—urinary bladder cancer	0.00108	0.00411	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.00107	0.00406	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00106	0.00327	CcSEcCtD
Ethanolamine Oleate—Chest pain—Epirubicin—urinary bladder cancer	0.00104	0.00319	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—IL2—urinary bladder cancer	0.00102	0.00387	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—ERBB2—urinary bladder cancer	0.001	0.00381	CbGpPWpGaD
Ethanolamine Oleate—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000996	0.00306	CcSEcCtD
Ethanolamine Oleate—Chest pain—Doxorubicin—urinary bladder cancer	0.000961	0.00295	CcSEcCtD
Ethanolamine Oleate—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000921	0.00283	CcSEcCtD
Ethanolamine Oleate—F12—Hemostasis—EP300—urinary bladder cancer	0.000916	0.00347	CbGpPWpGaD
Ethanolamine Oleate—Pain—Methotrexate—urinary bladder cancer	0.00091	0.0028	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism—NQO1—urinary bladder cancer	0.000904	0.00343	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	0.000903	0.00342	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—SRC—urinary bladder cancer	0.000891	0.00338	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00089	0.00338	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000877	0.00332	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—MMP9—urinary bladder cancer	0.000861	0.00327	CbGpPWpGaD
Ethanolamine Oleate—Pain—Epirubicin—urinary bladder cancer	0.000851	0.00262	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Methotrexate—urinary bladder cancer	0.000841	0.00258	CcSEcCtD
Ethanolamine Oleate—FABP4—Developmental Biology—EP300—urinary bladder cancer	0.000816	0.0031	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—SRC—urinary bladder cancer	0.000794	0.00301	CbGpPWpGaD
Ethanolamine Oleate—Pain—Doxorubicin—urinary bladder cancer	0.000788	0.00242	CcSEcCtD
Ethanolamine Oleate—Body temperature increased—Epirubicin—urinary bladder cancer	0.000787	0.00242	CcSEcCtD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000765	0.0029	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTP1—urinary bladder cancer	0.000754	0.00286	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—KRAS—urinary bladder cancer	0.000738	0.0028	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000729	0.00277	CbGpPWpGaD
Ethanolamine Oleate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000728	0.00224	CcSEcCtD
Ethanolamine Oleate—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	0.000722	0.00274	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—TYMS—urinary bladder cancer	0.000701	0.00266	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	0.0007	0.00265	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—EGFR—urinary bladder cancer	0.000696	0.00264	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—NCOR1—urinary bladder cancer	0.000693	0.00263	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GSTM1—urinary bladder cancer	0.000693	0.00263	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—GPX1—urinary bladder cancer	0.000663	0.00252	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—TNF—urinary bladder cancer	0.000663	0.00251	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—KRAS—urinary bladder cancer	0.000657	0.00249	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—TP53—urinary bladder cancer	0.000656	0.00249	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—ERCC2—urinary bladder cancer	0.000651	0.00247	CbGpPWpGaD
Ethanolamine Oleate—F12—Hemostasis—HRAS—urinary bladder cancer	0.000627	0.00238	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—MTHFR—urinary bladder cancer	0.000612	0.00232	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Developmental Biology—HRAS—urinary bladder cancer	0.000559	0.00212	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PPARG—urinary bladder cancer	0.000496	0.00188	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000485	0.00184	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000479	0.00181	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—CREBBP—urinary bladder cancer	0.000477	0.00181	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000446	0.00169	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00044	0.00167	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTGS2—urinary bladder cancer	0.00039	0.00148	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—PTEN—urinary bladder cancer	0.00034	0.00129	CbGpPWpGaD
Ethanolamine Oleate—FABP4—Metabolism—EP300—urinary bladder cancer	0.000325	0.00123	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000297	0.00113	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000282	0.00107	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000282	0.00107	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000258	0.000977	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000232	0.00088	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000219	0.000831	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000214	0.00081	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TYMP—urinary bladder cancer	0.000171	0.000647	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NAT2—urinary bladder cancer	0.000154	0.000586	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—RRM2—urinary bladder cancer	0.000133	0.000505	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	0.000123	0.000468	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ENO2—urinary bladder cancer	0.000123	0.000468	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	0.00012	0.000454	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NQO1—urinary bladder cancer	9.95e-05	0.000377	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	8.3e-05	0.000315	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—TYMS—urinary bladder cancer	7.71e-05	0.000293	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	7.63e-05	0.000289	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	7.63e-05	0.000289	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—GPX1—urinary bladder cancer	7.3e-05	0.000277	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	7.17e-05	0.000272	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	6.74e-05	0.000256	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PPARG—urinary bladder cancer	5.46e-05	0.000207	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	5.25e-05	0.000199	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	4.3e-05	0.000163	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—PTEN—urinary bladder cancer	3.75e-05	0.000142	CbGpPWpGaD
Ethanolamine Oleate—CYP2E1—Metabolism—EP300—urinary bladder cancer	3.58e-05	0.000136	CbGpPWpGaD
